EICHOR
● Recruiting
Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors
Condition: Metastatic Cancer · Metastatic Breast Cancer · Metastatic Lung Cancer · Sponsor: Williams Cancer Foundation
About this study
SV-101 is intended to overcome the complex and multifactorial nature of the mechanisms mediating tumor immune evasion, by the use of a combination of therapeutic agents that elicit multiple immuno-pharmacologic effects.
This description comes directly from the study's public registry record.
Talk to the study team
Jason Williams, MD · (954) 530-4606 · dr@williamscancerinstitute.com
Eduardo Cortés · +52 55 5507 9739 · eduardo@cancerimmunebio.com
Always discuss trial participation with your own doctor first.
Locations (1)
| Hospital Diomed | Mexico City, Mexico | Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05544240